Target, silence, replace: a review on RNA-based drugs in modern medicine
Poonam Mundlia, Suraj Pratap Singh, Pritiman Pothal, Tanya Thakur, Reema Kathuria, Sudhanshu Maurya, Akanksha Sharma, Honey Goel, Ankur Pandey, Pavitra Ranawat, Gurpal Singh, Ravi Pratap Barnwal · 2026
Read Target, silence, replace: a review on RNA-based drugs in modern medicine by Poonam Mundlia, Suraj Pratap Singh, Pritiman Pothal, Tanya Thakur, Reema Kathuria, Sudhanshu Maurya, Akanksha Sharma, Honey Goel, Ankur Pandey, Pavitra Ranawat, Gurpal Singh, Ravi Pratap Barnwal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13575629.txt.
Description
Poonam Mundlia and co-authors review RNA-based drugs, treatments that target, silence, or replace RNA to treat disease at its source. Their 2026 review starts from the field's arc: RNA agents now act on RNA, DNA, and protein alike, thanks to gains in making, modifying, and delivering them. Several are approved, and more are in trials.
Three families anchor the survey: small interfering RNA that silences a gene, messenger RNA that delivers a fresh message, and antisense strands that block one. The mRNA vaccine surge during COVID-19 showed the platform's speed. The review covers how each family works and the delivery tricks that ferry RNA into cells intact.
Catalog record
| CREATOR | Poonam Mundlia, Suraj Pratap Singh, Pritiman Pothal, Tanya Thakur, Reema Kathuria, Sudhanshu Maurya, Akanksha Sharma, Honey Goel, Ankur Pandey, Pavitra Ranawat, Gurpal Singh, Ravi Pratap Barnwal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 129 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |